Evidence map›Paper›PMID 42717445›Full record

ArticleBioinformatics (Oxford, England)2026

Identifying multigenic modules under selection in the tumor genome.

Marcus R Kelly, Burçak Otlu, Roded Sharan, Trey Ideker

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marcus R KellySchool of Medicine, University of California San Diego, La Jolla, CA, United States.
Burçak OtluMoores Cancer Center, UC San Diego, La Jolla, CA, United States.
Roded SharanBlavatnik School of Computer Science and AI, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0001-8363-4882
Trey IdekerSchool of Medicine, University of California San Diego, La Jolla, CA, United States.ORCID 0000-0002-1708-8454

Funding

The Cancer Cell Map Initiative v2.0U54CA274502 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emma Lundberg · 2022 to 2026
$14.2M
Using Networks to Seed Hierarchical Whole-cell Models of CancerU54CA209891 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KREISBERG, JASON FRANCIS · 2017 to 2021
$10.9M
Predoctoral and Postdoctoral Training in Cancer Cell BiologyT32CA067754 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEAN Y.J. WANG · 1995 to 2026
$6.5M
Advanced Research Projects Agency for Health 140D042590013Israel Science Foundation 1692/24Middle East Technical University AGEP-704-2024-11495NCI NIH HHS T32 CA067754NCI NIH HHS T32CA067754NCI NIH HHS U54 CA209891NCI NIH HHS U54CA209891NCI NIH HHS U54 CA274502NCI NIH HHS U54CA274502
6 · The paper itself

Abstract

motivationGenomic alterations in cancer arise from selective pressures acting on hallmark molecular modules, layered over a background of random mutagenic events. Methods to detect selection at the level of modules, as opposed to genes or nucleotides, are relatively underdeveloped.

resultsHere we present CanSRMaPP (Cancer Selection Recovery by Maximum Posterior Probability), a Bayesian model of the cancer genome that infers mutational selection on single genes and multi-genic modules while simultaneously modeling background events. Applying CanSRMaPP to lung adenocarcinoma genomes, we identify positive selection on 63 modules, yielding a model that parsimoniously explains the observed pattern of genetic alterations observed in new cancer cohorts. We further show that CanSRMaPP is adaptable to more tumor types and to alternative module definitions. We show that these modules serve as an effective scaffold for translating the cancer genome to molecular states, with prediction of cancer biomarker status as demonstration. AVAILABILITY: CanSRMaPP is freely available on GitHub.

Indexed as

Genome, HumanGenomicsNeoplasmsSelection, GeneticBayes TheoremHumansMutation

Identifiers

PMID42717445
PMCPMC13615650

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.